Chinese english Germany Japanese Korea

3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate

3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate Struktur
1192189-69-7
CAS-Nr.
1192189-69-7
Englisch Name:
3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate
Synonyma:
LX7101;CS-2042;LX7101 HCL;LX7101 (LX-7101);LX7101 (3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo;inhibit,Inhibitor,LX 7101,LX7101,Rho-associated protein kinase,Rho-associated kinase,ROCK,LX-7101,Rho-kinase,ROK;3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate;3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl N.N-dimethylcarbamate;LX7101 (3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate;N,N-Dimethylcarbamic acid 3-[[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]carbonyl]amino]phenyl ester
CBNumber:
CB42638542
Summenformel:
C23H29N7O3
Molgewicht:
451.52
MOL-Datei:
1192189-69-7.mol
Request For Quotation

3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate Eigenschaften

Dichte
1.327±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
insoluble in H2O; insoluble in EtOH; insoluble in DMSO
Aggregatzustand
solid
pka
13.96±0.70(Predicted)
Farbe
White to off-white

Sicherheit

3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate Chemische Eigenschaften,Einsatz,Produktion Methoden

3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 43)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Biochempartner 		0086-13720134139
candy@biochempartner.com CHINA 967 58
Hubei Jusheng Technology Co.,Ltd. 		18871490254
linda@hubeijusheng.com CHINA 28180 58
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD 		86-571-88216897,88216896 13588875226
 sales@hzclap.com CHINA 6313 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
Suzhou ARTK Medchem Co., Ltd. 		+8618168183658
 sales1@artkmedchem.com China 39009 58
Amadis Chemical Company Limited 		571-89925085
sales@amadischem.com China 131980 58
Shanghai Boyle Chemical Co., Ltd.
sales@boylechem.com China 2923 55
BOC Sciences 1-631-485-4226; 16314854226
 info@bocsci.com United States 14059 65
Haoyuan Chemexpress Co., Ltd. 021-58950125
info@chemexpress.com China 7553 61

1192189-69-7()Verwandte Suche:

Bis(pentamethylen)harnstoff 1-Phenethylpiperidin-4-ol
  • N,N-Dimethylcarbamic acid 3-[[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]carbonyl]amino]phenyl ester
  • 3-(4-(aMinoMethyl)-1-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperidine-4-carboxaMido)phenyl diMethylcarbaMate
  • LX7101
  • LX7101 HCL
  • Carbamic acid, N,N-dimethyl-, 3-[[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]carbonyl]amino]phenyl ester
  • LX7101 (3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
  • CS-2042
  • LX7101 (LX-7101)
  • 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl N.N-dimethylcarbamate
  • LX7101 (3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo
  • inhibit,Inhibitor,LX 7101,LX7101,Rho-associated protein kinase,Rho-associated kinase,ROCK,LX-7101,Rho-kinase,ROK
  • 1192189-69-7
  • C23H30ClN7O3
Copyright 2019 © ChemicalBook. All rights reserved